Lyra Therapeutics (LYRA) Financial Statements

362 Followers

Lyra Therapeutics Financial Overview

Lyra Therapeutics's market cap is currently $1.29M. The company's EPS TTM is $-18.62; its P/E ratio is -1.72; Lyra Therapeutics is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 398.00K	$ 1.53M	$ 1.56M	$ 1.36M	$ 285.00K
Gross Profit	$ 398.00K	$ 1.53M	$ 1.56M	$ 1.36M	$ -29.41M
Operating Income	$ -31.02M	$ -96.35M	$ -67.12M	$ -56.31M	$ -43.62M
EBITDA	$ -29.09M	$ -60.26M	$ -65.25M	$ -53.92M	$ -42.61M
Net Income	$ -28.92M	$ -93.44M	$ -62.68M	$ -55.28M	$ -43.51M
Balance Sheet
Cash & Short-Term Investments	$ 15.89M	$ 40.58M	$ 102.75M	$ 97.89M	$ 45.75M
Total Assets	$ 36.11M	$ 66.35M	$ 142.60M	$ 109.97M	$ 54.87M
Total Debt	$ 30.26M	$ 34.38M	$ 26.88M	$ 4.18M	$ 1.45M
Net Debt	$ 14.37M	$ -6.20M	$ 4.53M	$ -28.37M	$ -44.29M
Total Liabilities	$ 46.83M	$ 54.75M	$ 53.18M	$ 29.21M	$ 20.55M
Stockholders' Equity	$ -10.72M	$ 11.59M	$ 89.42M	$ 80.75M	$ 34.32M
Cash Flow
Free Cash Flow	$ -28.98M	$ -72.35M	$ -64.35M	$ -43.55M	$ -29.20M
Operating Cash Flow	$ -28.86M	$ -70.01M	$ -63.30M	$ -43.38M	$ -25.82M
Investing Cash Flow	$ -98.00K	$ 80.31M	$ -12.58M	$ -65.01M	$ -3.38M
Financing Cash Flow	$ 4.27M	$ 8.53M	$ 65.69M	$ 96.26M	$ 359.00K

Currency in USD

Lyra Therapeutics Earnings and Revenue History

Income Statement >

Lyra Therapeutics Debt to Assets

Balance Sheet >

Lyra Therapeutics Cash Flow

Cash Flow >

Lyra Therapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >